Definition
Key Takeaways BioNTech reported fourth-quarter profit and sales that were well below estimates on falling demand for COVID-19 vaccines.The company said writedowns of inventory from its partner Pfizer lowered revenue by 291.3 million euros ($315.9 million) in the quarter.BioNTech's full-year sales outlook also missed analysts' forecasts. American depositary receipts (ADRs) of BioNTech (BNTX) tumble
In Panel Profits
In the Panel Profits market platform, BioNTech Tumbles as Q4 Profit, Sales Trail Estimates on Falling COVID-19 Vaccine Demand applies standard financial concepts principles to comic assets and physical collections.
Common mistakes
Do not infer unobserved prices.